ICON's AI strategy: faster, smarter trials

This week on The Pharma Letter Podcast, we are joined by Tony Clarke, senior VP of IT digital operations at ICON (Nasdaq: ICLR).As a leader in digital transformation within clinical research, Tony has been at the forefront of implementing AI-driven solutions to enhance drug development. A global contract research organization (CRO), ICON has been tracking industry attitudes toward digital innovation. In 2019, the company conducted a survey to gauge investment trends in new technologies, and now, five years later, a new study reveals how perceptions and adoption have evolved. While the rise of AI, particularly generative AI, has dominated the debate across industries, we consider how it is truly shaping clinical research, including potential barriers to adoption.We’ll also talk about how digital tools are driving efficiencies in drug development, and what the future holds for technology in clinical trials.Partnered content.